Aerie Pharmaceuticals, Inc. Added To NASDAQ Biotechnology Index (NBI)

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that it has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ:^NBI), which will become effective upon market open on Monday, December 22, 2014.

Help employers find you! Check out all the jobs and post your resume.